Literature DB >> 2043852

The promise of a reformed NHS: an economist's angle.

A J Culyer1.   

Abstract

Mesh:

Year:  1991        PMID: 2043852      PMCID: PMC1669931          DOI: 10.1136/bmj.302.6787.1253

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Economics of coronary artery bypass grafting.

Authors:  A Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

2.  The medical literature. Let the reader beware.

Authors:  T J Sheehan
Journal:  Arch Intern Med       Date:  1980-04

3.  Biostatistics: how to detect, correct and prevent errors in the medical literature.

Authors:  S A Glantz
Journal:  Circulation       Date:  1980-01       Impact factor: 29.690

4.  Steps towards cost-benefit analysis of regional neurosurgical care.

Authors:  J D Pickard; S Bailey; H Sanderson; M Rees; J S Garfield
Journal:  BMJ       Date:  1990-09-29
  4 in total
  7 in total

1.  Economic evaluation of drugs: a UK pharmaceutical industry perspective.

Authors:  N Wells
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

2.  Health economics in primary care in the UK: containment of drug costs.

Authors:  T Walley; R T Edwards
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

3.  Improving the quality of health care through contracting: a study of health authority practice.

Authors:  J D Gray; L J Donaldson
Journal:  Qual Health Care       Date:  1996-12

4.  A methodological quibble about QALYs.

Authors:  L McTurk
Journal:  BMJ       Date:  1991-06-29

5.  Clinical guidelines: development, implementation, and effectiveness.

Authors:  C W Onion; T Walley
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

Review 6.  Equity and community child health.

Authors:  R Reading
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

Review 7.  Defining equity in health.

Authors:  P Braveman; S Gruskin
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.